Authors

WISeR Spending or Unneeded Delays in Healthcare? Prior Authorizations, AI in Medicare Prompt Concerns

The new Medicare payment model aims to take down wasteful spending, but Congress and analysts point out potential problems.

How AI Orchestration Is Reinventing Healthcare Supply Chain Resilience

By unifying data, workflows, and decision-making across partners, AI orchestration is enabling healthcare supply chains to move from reactive firefighting to proactive resilience—supporting faster responses, smarter tradeoffs, and more reliable patient care delivery.

Why Trust Is the Biggest Barrier to Supply Chain Transparency

In the final part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, explains how federated intelligence, audit-ready data systems, and a culture of compliance are enabling scalable transparency across decentralized pharmaceutical manufacturing networks.

Drug Pricing, PBM Reform, and the 2026 Midterms: What You Need to Know

Avalere Health analysts map the converging pressures reshaping the drug pricing and distribution landscape ahead of November.

From Uncertainty to Opportunity: Navigating IPAY 2028

How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care

What Will Actually Bend the Healthcare Cost Curve?

In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, points out that from biosimilars and site-of-care shifts to AI, value-based reimbursement, and potential legislative action, market deflators—not simple cost shifting—will determine whether affordability improves across employer-sponsored plans, Medicaid, and Medicare.

De-Risking Clinical Development: Strategic Multipliers in Global Trials

How Biopharma Companies Can Optimize Field Reimbursement Models

In the final part of her Pharma Commerce video interview, Megan Wetzel, VP, product, access & affordability at CoverMyMeds, shares how the right field reimbursement model structure ensures field teams have the insights and tools they need to overcome coverage barriers and accelerate patient access to therapy.

Pharma Pulse: Regulatory Speed Records

In today’s Pharma Pulse, the FDA grants a lightning-fast approval for Boehringer’s lung cancer therapy under its new priority program, while CMS Administrator Mehmet Oz launches a sweeping offensive against fraudulent billing.

How Digital Strategies Transform Pharma Supply Chains in 2026

Pharma supply chains are embracing AI, digital twins, IoT, and DSCSA-driven traceability to improve resilience, visibility, and profitability amid rising global disruptions.

Modernizing GxP Compliance in Life Sciences: The Role of Digital Tools and Validation Expertise

In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital tools like eQMS, cloud platforms, and automated validation, while expert validation services remain essential for aligning these technologies with real-world workflows and inspection readiness.

Changing the PAP Model

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

Specialty Dispensing Insights: A clearer view of oral utilization trends from medically integrated dispensing community practices

Specialty Dispensing Insights delivers practice, clinic, and physician level perspective on oral therapy use within medically integrated dispensing (MID) pharmacies, including dose and days’ supply metrics, ZIP based activity, competitive prescribing, and trends in new patient starts. These insights offer clear visibility into how oral therapies are utilized within MID practices, helping teams understand the unique prescribing dynamics, geographic variation, and competitive activity across real-world community settings.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

Finding the Human Touch in a Wired World

In the final part of her Pharma Commerce video interview, Jen Butler, CCO at Pleio, emphasizes that as digital tools become central to patient support, there is value to balancing technology with empathy.

Greener, Smarter, and Less Expensive: How Pharma Packaging is Evolving

As the sentiment of surveyed dangerous goods experts backs up, updated packaging pursuits can boost efficiency and cut costs—while mitigating the environmental impact.

Measuring What Matters

Ways to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.

From Aisles to Access: How Grocery-Based Pharmacies are Evolving into Community Health Hubs

Amid the growing crisis of pharmacy deserts, these entities are tapping new avenues in care delivery, including the integration of clinical services, nutrition counseling, and real-time patient education.

Pharma's Year of Two Halves

What 2025 means for the life sciences sector in the New Year.

Advancing Circular Economy Packaging in Pharmaceutical Cold Chain

How Healthcare Organizations Can Balance Federal and State AI Regulations

In the third part of her Pharma Commerce video interview, Linda Malek, JD, partner at Crowell & Moring, explains how healthcare organizations can harmonize both approaches by prioritizing fairness, transparency, and adaptable systems.

Could Trump's New Drug Tariffs Shift Pharma Supply Chain Strategy?

Pharma companies could face 100% tariffs under new US rules, with relief available for those prioritizing onshore manufacturing or pricing concessions.

The First Dose Is Everything: How Noble’s SureStartRx™ Program Improves Adherence and Persistence

Have 503B Outsourcing Facilities Truly Reduced US Drug Shortages?

Despite steady growth since the Drug Quality and Security Act, outsourcing facilities remain constrained in scale and scope, offering targeted mitigation rather than systemic relief for persistent shortages.

Flat 2027 Medicare Advantage Rates Signal Tighter Budgets—and Tougher Access Ahead

CMS’s CY 2027 Medicare Advantage rates signal mounting cost pressure, setting the stage for tighter benefits, tougher contracting, and heightened access scrutiny in the months ahead.

Reducing Risk in the Pharmaceutical Cold Chain

When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

Qualified Temperature-Controlled Corridors: The Future is Here

Webinar Date/Time: Tuesday, April 7, 2026 at 10 AM EDT I 3 PM GMT I 4 PM CET

LogiPharma USA 2025: Pharma Supply Chains Evolve Toward Real-Time Visibility and End-to-End Control

At LogiPharma USA, industry leaders from Tive, McKesson, and the broader healthcare logistics community discussed the sector’s transition from passive monitoring to real-time control, the growing influence of advanced therapies, and the importance of diversity and innovation in shaping the future of pharma supply chains.

Point-of-Care Isn’t a Marketing Tactic—It’s a Gross-to-Net Strategy

Chris Dowd and Lisa Prowker of ConnectiveRx discuss point-of-care marketing as the key activation layer for investments in patient access and support—it’s essential for converting dollars spent in payer negotiations and copay programs into prescriptions.